Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Pauling.AI Announces Launch of Fully Automated Drug Discovery Agent for Small Molecules

By: Prodigy
10/06/2025, Boston, MA // PRODIGY: Feature Story //

Pauling.AI, an AI-first biotech company, today announced the launch of its fully automated drug discovery agent for small molecules. The agent orchestrates end-to-end in-silico workflows, including target ingestion, molecular generation and screening, docking, molecular dynamics, and ADMET prediction, so scientists can move from hypothesis to testable candidates dramatically faster and at lower cost. Pauling.AI aims to build the best possible AI drug discovery workflow.

“AI agents should feel like a world-class computational chemist that never sleeps,” said Javier Tordable, Founder & CEO of Pauling.AI and a former Google technology leader. “By automating the heavy lifting (simulation, triage, and documentation) we let teams focus on the science that matters: choosing the right biology and advancing the best molecules.”

Pauling.AI builds AI agents that automate drug discovery.
Pauling.AI

Early materials describe Pauling.AI as “the AI chemist that automates drug discovery,” highlighting autonomous workflows for docking and simulation, and positioning the platform to help startups go from idea to testable molecule in less than a week. The company participates in the NVIDIA Inception program and lists Google for Startups among supporters.

Agentic systems are emerging across pharma, Pauling.AI’s launch focuses currently on small-molecule programs and emphasizes turnkey automation over point tools, integrating generation, physics-based evaluation, and developability checks in one loop.

Availability

Pauling.AI’s fully automated small-molecule agent is available today to selected biotech and pharma partners. Teams interested in pilots can inquire via the company’s website. pauling.ai

About Pauling.AI

Pauling.AI builds AI agents that automate drug discovery. Headquartered in Boston, MA, the company’s platform compresses early discovery timelines by automating computational chemistry and in-silico candidate triage. Pauling.AI is led by Javier Tordable (ex-Google) and is a member of NVIDIA Inception.

###

Media Contact:

info@pauling.ai 

pauling.ai





newsroom: news.38digitalmarket.com



Source: 38 Digital Market News

Release ID: 1846118

Source published by Submit Press Release >> Pauling.AI Announces Launch of Fully Automated Drug Discovery Agent for Small Molecules


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.